Ehlers-danlos syndrome with platelet dysfunction due to fibronectin abnormality Q79.6

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

EDS10; EDS Type X; EDS X; Ehlers-Danlos syndrome, dysfibronectinemic type; Ehlers-Danlos syndromes, fibronectin-deficient type; Ehlers-Danlos syndrome type X; Ehlers Danlos syndrome with platelet dysfunction from fibronectin abnormality; ORPHA:75501

Definition
This section has been translated automatically.

Very rare (so far only described in a few families), autosomal recessive variant of the Ehlers-Danlos syndrome with superficial dysfunction of fibronectin.

Clinical features
This section has been translated automatically.

Arneson et al (1980) observed mild EDS in 4 out of 6 siblings together with a defect in platelet aggregation in response to collagen. The defect could be partially corrected by normal plasma.

Already in this first study it was assumed that a functionally abnormal fibronectin was present, since fibronectin is an important connective tissue adhesion glycoprotein and is the putative collagen receptor of platelets. Petechiae occur due to the platelet defect.

Note(s)
This section has been translated automatically.

The autonomy of this EDS variant is now controversial (see classification in EDS)

Literature
This section has been translated automatically.

  1. Arneson M A et al (1980) A new form of Ehlers-Danlos syndrome: fibronectin corrects defective platelet function. JAMA 244: 144-147
  2. Hammerschmidt DE et al (1982) Maternal Ehlers-Danlos syndrome type X: successful management of pregnancy and parturition.JAMA 248: 2487-2488

Outgoing links (1)

Ehlers-danlos syndrome;

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020